Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/2005
03/16/2005CN1593425A Compound hyacinth bletilla minipill
03/16/2005CN1593421A Compound formulation for preventing and treating broiler ascites syndrome
03/16/2005CN1593420A Ginkoleaf extract and diphyridamole powder injection and its preparation
03/16/2005CN1593393A Prescription of liquid status of Vitamin K1 and its preparation
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1192800C Trapping agent for blood carbonyl compounds
03/16/2005CN1192785C Haemostatic 'Gonghuan' tablet and preparing process
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867215 Cardioprotective phosphonates and malonates
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/15/2005US6867206 6-carboxyphenyldihydropyridazinone derivatives and use thereof
03/15/2005US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
03/15/2005US6867200 Anticancer agents; anticoagulants
03/15/2005US6867190 Methods of therapy with thrombin derived peptides
03/15/2005US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
03/15/2005US6866851 GFRα1-RET specific agonists and methods therefor
03/15/2005CA2334870C Polymorphic form of clopidogrel hydrogen sulphate
03/10/2005WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative
03/10/2005WO2004097320A8 Thermal energy storage
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003103475A3 Prevention and reduction of blood loss
03/10/2005WO2003092720A8 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases
03/10/2005US20050054712 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
03/10/2005US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054653 Pteridine derivatives, method of producing them and their application
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050054617 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
03/10/2005US20050054595 Genetic engineering; gene expression of target agent
03/10/2005US20050054579 New crystalline forms
03/10/2005US20050054567 Polypeptides; adjust concentration of stem cells
03/10/2005US20050054508 Control device for the separate collection of blood components in output from a blood centrifugation cell
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053548 Degrading collagen within an atherosclerotic plaque in a chronically occluded animal tube or cavity by administering proteolytic enzyme; angioplasty
03/10/2005US20050053516 antiseptic mixtures of quaternary ammonium compounds and carriers, for use in disinfecting fluids and biological tissues and surfaces contaminated with fluids and/or biological tissues
03/09/2005EP1512739A1 Chrondrocyte therapeutic delivery system
03/09/2005EP1512464A2 Control device for the separate collection of blood components in output from a blood centrifugation cell
03/09/2005EP1512398A1 Intravascular stent with cytoskeletal inhibitors for the prevention of restenosis
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511859A1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene
03/09/2005EP1511853A2 Regulation of novel human asparagine-hydroxylases
03/09/2005EP1511774A1 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions
03/09/2005EP1511770A2 Immunoadhesin comprising a glycoprotein vi domain
03/09/2005EP1511757A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511511A2 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
03/09/2005EP1511502A2 Probiotic therapies using lactobacillus reuteri
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound
03/09/2005EP1511480A2 Inhibitors of glycoprotein vi
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP0973504B1 Hemostatic aerosol composition
03/09/2005EP0944645B1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005EP0756005B1 Gene coding for adseverin
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592744A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592634A Non-neurotoxic plasminogen activating factors for treating stroke
03/09/2005CN1592632A Combined use of VII polypeptides and factor VIII polypeptides
03/09/2005CN1590407A Multifunctional blood forming receptor agonist
03/09/2005CN1589894A Medicinal composition for treating parafunctional metrorrhagia and its preparation method
03/09/2005CN1589870A Incised wound medicine
03/09/2005CN1589832A Medicine for boosting qi and nourishing blood and its prepatation method
03/09/2005CN1589811A Medicinal composition, its preparation method and its use
03/09/2005CN1192109C Anticoagulant fusion protein anchored to cell membrane
03/09/2005CN1192105C A variant of C6 beta-chemokine leukotactin-1(shLKn-1) with enhanced biological activity
03/09/2005CN1192037C Signal sequence for production of leu-hirudine via secretion by E coli in culture medium
03/09/2005CN1192019C Cyclic amine derivatives
03/09/2005CN1191864C Hemoglobin-polysaccharide conjugates
03/09/2005CN1191856C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
03/09/2005CN1191837C Method for producing Chinese medicine for curing cardio-cerebrol vascular disease
03/09/2005CN1191754C Preserving hemoglobin blood substitute with transparent overwrap
03/08/2005US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
03/08/2005US6864287 Cardiovascular disorders; hypotensive agents
03/08/2005US6864282 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
03/08/2005US6864280 Hypotensive agents; cardiovascular disorders
03/08/2005US6864279 2h-chromene derivatives metabolized both by cytochrome P450 and by a non-oxidative metabolic enzyme or system of enzymes; do not cause metabolic DDI when co-administered with other drugs
03/08/2005US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders
03/08/2005US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer
03/08/2005US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
03/08/2005US6864094 Method of preserving oxygen infusions
03/08/2005US6863903 Pharmaceutical product comprising anti-secretory protein from egg yolk
03/08/2005US6863902 Mixture of methyl hydrogen 9,11 alpha-epoxy-17 alpha-hydroxy-3-oxopregn-4-ene-7-alpha, 21-dicarboxylate, gamma-lactone and carriers administered as aldosterone receptor antagonists, for prophylaxis of cardiovascular disorders
03/08/2005CA2480712A1 Chondrocyte therapeutic delivery system
03/03/2005WO2005019441A1 Method of differentiation from embryo-stem cell of primate to hematogenous cell
03/03/2005WO2005018649A1 Agent for inhibiting the formation of final saccharification product
03/03/2005WO2004104004A3 Triaza-spiro compounds as nociceptin analogues and uses thereof
03/03/2005WO2004101553B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/03/2005WO2004071395A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r)
03/03/2005WO2003102151A3 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors
03/03/2005US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same
03/03/2005US20050049303 Adamantane derivatives
03/03/2005US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
03/03/2005US20050049283 Compounds that inhibit factor xa activity
03/03/2005US20050049251 Inhibitors of p38
1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 671